Agilent Technologies has expanded its collaboration with Monash University Malaysia (MUM) for the establishment of the MUM Proteomics & Metabolomics Platform (MUMPMP)-Agilent BioDiscovery Hub.

The initiative aims to enhance biotechnology research and innovation in the region.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The new memorandum of understanding (MOU) was signed to mark the 15-year collaboration between the two organisations.

The agreement highlights Agilent’s ongoing support for research and development (R&D) in rapidly growing Asian markets.

As part of the renewed partnership, Agilent will provide advanced equipment, including its Revident Quadrupole Time of Flight liquid chromatography-mass spectrometry (LC/MS) systems, the 1290 Infinity III High-Performing LC series and the 5977C Gas Chromatography/MSD.

These instruments will be placed at the new hub to facilitate research programmes, workshops, the development of applications and scientific training.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The partnership is intended to expedite R&D in small and large molecule analysis, supporting progress in the pharmaceutical, biomedical and molecular biology sectors.

Department of Molecular Epidemiology & Translational Medicine and the MUM Proteomics & Metabolomics Platform director and Biomedical Science senior lecturer Dr Syafiq Asnawi stated: “The MUMPMP–Agilent BioDiscovery Hub strengthens Monash’s position as a regional leader in proteomics, metabolomics and biotechnology innovation.

“By combining Agilent’s state-of-the-art technologies with Monash’s research excellence and multidisciplinary ecosystem, we are empowering our scientists and partners to drive impactful solutions for Malaysia and the Asia-Pacific region.”

Agilent, which has operated in Malaysia for more than two decades, continues to support the country’s scientific development through partnerships with academic institutions and workforce training initiatives.

Agilent Technologies Asia Pacific sales vice-president Bharat Bhardwaj stated: “At Agilent, we support Monash University in enhancing biological research through proteomics, metabolomics and lipidomics.

“The BioDiscovery Hub will drive scientific progress, talent development and creating long-term value for customers and partners.”

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Imagene’s Oncology Intelligence (OI) Suite has won the Innovation Award for Precision Oncology, for transforming how pharma designs and runs oncology trials. From AI-driven biomarker discovery to smarter patient stratification, see how Imagene is cutting time, cost and risk in cancer drug development.

Discover the Impact